$76.5B
$121 Million
0.06% of portfolio
75
Q2 2023
New
$63.8B
$123 Million
0.06% of portfolio
1,427
Q2 2025
Added 89.26%
$0
$128 Million
0.06% of portfolio
1,749
Q2 2025
Reduced 7.26%
$0
$138 Million
0.06% of portfolio
3,493
Q2 2025
Reduced 2.51%
$50.4M
$129 Million
0.06% of portfolio
25,863
Q1 2024
Reduced 50.0%
$75.3B
$135 Million
0.06% of portfolio
3,800
Q2 2023
New
$22.4B
$131 Million
0.06% of portfolio
1,400
Q2 2023
New
$0
$138 Million
0.06% of portfolio
708
Q3 2024
Added 16.07%
$0
$137 Million
0.06% of portfolio
971
Q1 2025
Reduced 1.32%
$0
$132 Million
0.06% of portfolio
1,642
Q1 2025
Reduced 5.41%
$0
$123 Million
0.06% of portfolio
1,407
Q2 2024
Reduced 36.25%
$302B
$104 Million
0.05% of portfolio
1,293
Q1 2024
Reduced 7.84%
$29.2B
$114 Million
0.05% of portfolio
2,335
Q2 2024
Reduced 5.08%
$245B
$117 Million
0.05% of portfolio
467
Q2 2025
Reduced 27.82%
$1.31B
$102 Million
0.05% of portfolio
5,000
Q1 2025
Reduced 50.0%
$0
$105 Million
0.05% of portfolio
600
Q2 2025
Reduced 3.23%
$43.8B
$110 Million
0.05% of portfolio
1,230
Q3 2024
Added 173.33%
$0
$104 Million
0.05% of portfolio
236
Q1 2025
Reduced 12.59%
$0
$118 Million
0.05% of portfolio
902
Q1 2025
Added 50.33%
$12.9B
$117 Million
0.05% of portfolio
505
Q2 2023
New
$51B
$114 Million
0.05% of portfolio
1,945
Q3 2024
Added 9.89%
$15.2B
$103 Million
0.05% of portfolio
824
Q2 2023
New
$0
$111 Million
0.05% of portfolio
3,539
Q1 2025
Reduced 5.35%
Glaxo Smithkline PLC Adr New
-
$98.1 Million
0.05% of portfolio
-
Q1 2025
Added 5.01%
$0
$107 Million
0.05% of portfolio
583
Q2 2023
New
$101B
$102 Million
0.05% of portfolio
512
Q3 2024
Added 2.2%
$0
$86.6 Million
0.04% of portfolio
1,479
Q1 2024
Added 136.64%
$281B
$95.3 Million
0.04% of portfolio
973
Q3 2024
Added 11.45%
$254B
$78.9 Million
0.04% of portfolio
109
Q4 2024
Reduced 54.39%
$53B
$97.6 Million
0.04% of portfolio
2,475
Q2 2023
New
$36.8B
$93.9 Million
0.04% of portfolio
907
Q2 2023
New
$0
$86.6 Million
0.04% of portfolio
391
Q2 2025
Reduced 6.68%
$0
$87.7 Million
0.04% of portfolio
1,000
Q2 2024
Reduced 10.87%
$6.34B
$94 Million
0.04% of portfolio
750
Q2 2023
New
$55B
$77.1 Million
0.04% of portfolio
1,124
Q1 2024
Reduced 4.26%
$0
$91.4 Million
0.04% of portfolio
313
Q2 2025
Added 6.83%
$258B
$90.2 Million
0.04% of portfolio
1,249
Q3 2024
Reduced 12.6%
-
$93.4 Million
0.04% of portfolio
-
Q2 2025
Reduced 21.2%
$250B
$92.5 Million
0.04% of portfolio
649
Q3 2024
Added 30.06%
$0
$78.1 Million
0.04% of portfolio
190
Q2 2025
Reduced 25.78%
$94.4B
$95.5 Million
0.04% of portfolio
1,279
Q4 2024
Reduced 7.25%
$112B
$89.4 Million
0.04% of portfolio
336
Q2 2025
Reduced 23.81%
$60B
$94.3 Million
0.04% of portfolio
422
Q1 2024
Reduced 8.66%
$58.4B
$84.3 Million
0.04% of portfolio
1,929
Q2 2025
Added 34.99%
$71.7B
$73 Million
0.03% of portfolio
93
Q2 2023
New
$10.2B
$72.5 Million
0.03% of portfolio
1,258
Q2 2023
New
$141B
$67.4 Million
0.03% of portfolio
2,029
Q2 2025
Reduced 39.76%
$232B
$71.6 Million
0.03% of portfolio
277
Q1 2025
Added 78.71%
$119B
$56.6 Million
0.03% of portfolio
252
Q3 2024
Added 4.13%
$0
$63.7 Million
0.03% of portfolio
419
Q3 2024
Reduced 21.54%